XML 23 R8.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash flows from operating activities:    
Net earnings $ 258,036 $ 148,242
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Stock-based compensation expense 102,200 97,062
Depreciation 25,117 21,985
Impairment and amortization of intangibles 23,432 242,232
Deferred income taxes 26,627 (32,663)
Other adjustments, net 6,912 1,693
Changes in assets and liabilities    
Accounts receivable (83,074) 934
Other assets 2,128 30,562
Accounts payable and other liabilities (27,988) (476,056)
Income taxes payable and receivable 4,001 (15,089)
Deferred revenue (7,526) 1,062
Net cash provided by operating activities 329,865 19,964
Cash flows from investing activities:    
Capital expenditures (37,457) (27,305)
Other, net 89 1,787
Net cash used in investing activities (37,368) (25,518)
Cash flows from financing activities:    
Payments to settle exchangeable notes 0 (94,252)
Proceeds from the settlement of exchangeable note hedges 0 52,623
Payments to settle warrants related to exchangeable notes 0 (7,482)
Proceeds from issuance of common stock pursuant to stock-based awards 15,816 16,356
Withholding taxes paid on behalf of employees on net settled stock-based awards (2,580) (101,089)
Purchase of treasury stock (145,108) (190,980)
Purchase of noncontrolling interests (1,872) (10,554)
Other, net 0 10
Net cash used in financing activities (133,744) (335,368)
Total cash provided (used) 158,753 (340,922)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash 1,421 (10,786)
Net increase (decrease) in cash, cash equivalents, and restricted cash 160,174 (351,708)
Cash, cash equivalents, and restricted cash at beginning of period 572,516 815,512
Cash, cash equivalents, and restricted cash at end of period $ 732,690 $ 463,804